Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients
Clinical trial NCT06505369 · RECRUITING
Trial details
- NCT number
- NCT06505369
- Sponsor
- North Estonia Medical Centre
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2026-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.